MEDICAID NOTICE: Lurie Children’s continues to serve all patients enrolled in Medicaid. As a safety-net hospital, we will continue providing high-quality care to every child who needs us.

AVISO SOBRE MEDICAID: Lurie Children’s continúa atendiendo a todos los pacientes inscritos en Medicaid. Como hospital perteneciente a la red de protección social, continuaremos brindando atención de alta calidad a cada niño que nos necesite.

The Multidisciplinary Tuberous Sclerosis Complex (TSC) Clinic at Lurie Children's is among the top centers in the country providing comprehensive care for children of all ages with TSC. In addition to providing individualized care, our experts participate in research to contribute to the growth and development of treatment choices as we continue to search for a TSC cure.

The TSC Clinic consists of physicians, nurse practitioners, English- and Spanish-speaking social workers, genetic counselors, nurses, a TSC nurse coordinator and a school liaison/education specialist dedicated to treating all aspects of TSC. While our team is based in the Epilepsy Center at Lurie Children’s, we see all children with TSC regardless of presence of seizures. Our team also collaborates with other divisions at Lurie Children’s necessary to provide the best treatment for each child including dermatology, nephrology, pulmonology, cardiology, dentistry, ophthalmology and psychiatry.

Our clinic not only provides patients with comprehensive medical management of TSC, including dietary/metabolic therapy by partnering with our robust ketogenic diet program, but also surgical treatment by offering epilepsy surgery for select patients by working closely with our epilepsy-neurosurgery team, especially Drs. Sandi Lam and Jeffrey Raskin


What Is Tuberous Sclerosis Complex (TSC)?

Tuberous sclerosis complex (TSC) is a genetic disorder that can lead to the formation of benign tumor-like lesions in organs throughout the body. These primarily include the brain, eyes, heart, kidneys, lungs, oral cavity and skin. TSC affects each person differently with some people having more manifestations than others. Some manifestations of TSC may appear at birth while others may not appear until a child is older.

How Common Is TSC & What Causes It?

TSC affects about 1 million people worldwide and occurs in about 1 in every 6,000 births. TSC can occur in any individual regardless of their background or gender. 

TSC is a genetic disease that can be inherited from one parent with TSC or can result from a spontaneous genetic mutation. TSC is an autosomal dominant genetic condition, which means that children have a 50% chance of inheriting TSC if one of their parents has the condition. Researchers estimate that only one-third of TSC cases are known to be inherited while the other two-thirds result from a random and unpredictable mutation. 

How is TSC Diagnosed?

TSC can be diagnosed at various points in a person’s life.  

Prenatal diagnosis is possible through fetal ultrasound, especially if benign heart tumors are detected.  

Many cases are diagnosed within the first year of life, often due to the presence of skin lesions, such as hypomelanotic macules or facial angiofibromas. Sometimes seizures are the first noted symptom. 

The diagnosis can occur later in childhood if the symptoms develop more gradually, such as developmental delays or learning disabilities. 

Finally, in some milder cases, TSC may not be diagnosed until adolescence or even adulthood. 

What are Symptoms of TSC and Related Conditions?

Every child’s TSC clinical findings can vary and present differently. Several organ systems can be affected to varying degrees.

Seizures Epilepsy

Seizures are reported in up to 80% of patients with TSC, with focal seizures being the most common seizure type. Epilepsy in tuberous sclerosis is due to structural (tubers) and genetic etiology. 

Infantile Spasms

Infantile spasms are a specific type of seizure seen in infancy and is seen in 30% of patients with TSC. 

Brain Findings

Brain abnormalities seen in TSC on MRI include cortical tubers, subependymal nodules, and subependymal giant cell astrocytoma (SEGA). 

Renal (Kidney) Symptoms

Kidney cysts are the most common renal manifestation of TSC, and renal angiomyolipomas which are fat containing non-cancerous tumors are seen specifically in this condition.

Skin Symptoms

  • Hypopigmented macules - white "birthmarks” on the face and body 
  • Shagreen patch - patch of skin that is tough or dimpled similar to that of an orange peel
  • Facial angiofibroma - small red bumps or spot noted across nose, cheeks, chin

Heart Symptoms

  • Cardiac rhabdomyomas - Benign tumors that grows in clusters in the heart; these are seen usually in the newborn period and regress thereafter

Eye Symptoms

  • Retinal hamartomas - Nearly 50% of TSC patients have this involvement in one or both eyes, but vision loss is uncommon

Development Behavioral Symptoms

TSC-Associated Neuropsychiatric Disorders (TAND) includes a range of behavioral, intellectual, academic and psychiatric difficulties associated with TSC. 

  • Autism Spectrum disorder (ASD) is a common neuropsychiatric manifestation of TSC. 
  • Neuropsychiatric conditions: TSC is also associated with attention deficit hyperactivity disorder (ADHD), tic disorder, obsessive-compulsive disorder (OCD) and anxiety. 
  • Behavioral dysregulation, sleep dysregulation and aggressive behavior is also seen in some patients. 
  • Intellectual: TSC can impact intellectual functioning and can be a cause of a range of disabilities affecting academic performance including specific learning disabilities, reasoning and problem-solving, and deficits with social communication and executive functions, such as planning and organization and memory. 

Our TSC Team

Our team consists of board-certified pediatric neurologists, nurse practitioners, social workers, genetic counselors, nurses, a TSC nurse coordinator and a school liaison/education specialist with special training in the treatment and management of TSC.

Joyce Wu, MD

TSC Clinic Co-Director

Kelly Nelson, MSN, RN, CPN

TSC Nurse Coordinator

Erin McGinnis, MS, CGC

Genetic Counselor

Megan Keeler, LSW, MPH

Social Work

Arely Cerda, LSW

Social Work

What to Expect & Treatment

Currently, there is no known cure for TSC. Surveillance guidelines published by the TSC alliance and standard of care treatments are reviewed and tailored for each individual patent. Some treatment options for children with seizures include medications (anti-seizure medications, mTOR inhibitors), the ketogenic diet, epilepsy surgery, and neuromodulation.

Diagnostic Tests & Surveillance Imaging/Procedures

Make an Appointment

To schedule an appointment with a member of our team, call our Epilepsy Center. Phone lines are open Monday–Friday, 8 a.m.–4 p.m. CST. Your child’s primary care provider or another provider caring for your child may also send a referral to our office, please fax this to 312.227.9644.

Research

Lurie Children’s is a clinical trial site for the TSC-STEPS study to learn more about a drug known as Sirolimus. Learn more about the study. 

Our Recent Publications 

Resources & Support

Related News

Helping Families Navigate Drug-Resistant Pediatric Epilepsy with Dr. Sandi Lam

In this episode, Dr. Sandi Lam, Division Head of Neurosurgery at Lurie Children’s, talks about her work to help pediatric patients with Lennox-Gastaut syndrome and their families manage this condition by investigating the outcomes that matter most to patients and their families.

Read more

May 15th is Global Tuberous Sclerosis Complex Awareness Day

Lurie Children’s has a specialty clinic devoted to the diagnosis and care of children and families affected by TSC.

Read more